Atlas Trials

Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia

Clinical trial NCT01338298 · COMPLETED

Trial details

NCT number
NCT01338298
Sponsor
University of Maryland, Baltimore
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Hyperprolactinemia
Start date
2011-01-01
Primary completion
2016-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.